BioCentury
ARTICLE | Clinical News

IPL455: Phase I data

May 16, 2005 7:00 AM UTC

Data from a dose-escalation, placebo-controlled Phase I trial in 50 healthy volunteers showed that HT-0712 was safe, well tolerated and had an acceptable pharmacokinetic profile. In particular, the co...